Calm in a room: can sensory therapy soothe the mind?
NCT ID NCT07748078
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This trial tests whether Snoezelen therapy—a calming, multisensory experience using lights, sounds, and textures—can improve health in adults with schizophrenia (including those needing institutional care) and women with alcohol dependence. Participants will attend 30-minute sessions twice a week for 6 or 12 weeks. Researchers will measure changes in cognition, mood, anxiety, life satisfaction, daily functioning, and certain blood markers to see if this gentle therapy offers benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Snoezelen therapy, a multisensory relaxation intervention involving controlled visual, auditory, and tactile stimuli in a calming environment
- What this could lead to
- If effective, Snoezelen therapy could offer a drug-free, non-invasive way to ease symptoms and improve quality of life for people with schizophrenia or alcohol dependence.
- What could go wrong
- This is an early-stage trial with a modest number of participants, and results may not generalize. The therapy is supportive, not curative, and its benefits may vary widely between individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL DEPENDENCE (PRIMARY CONDITION) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Psychiatric Hospital SPZOZ in Rybnik, Poland
Rybnik, Silesian Voivodeship, 44-200, Poland
-
Jerzy Kukuczka Academy of Physical Education in Katowice, Poland
Katowice, Silesian Voivodeship, 40-065, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Role-Play with a simulated patient: a new way to train nurses in mental health?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?